Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Kurobe Pharmaceuticals
AddedFeb 17, 2024
UpdatedJun 18, 2026
Kurobe Pharmaceuticals

Kurobe Pharmaceuticals

Kurobe, a Tampa-based biopharma firm under Point Guard Partners, specializes in treating MRSA in the eye.

HQ
Tampa, FL, US
Founded
2012
Overview
Compare
Fundraising
Employees
Website

Kurobe Pharmaceuticals, based in Tampa, focuses on developing treatments for methicillin-resistant staphylococcus aureus (MRSA) infections in the eye. Founded under the umbrella of Point Guard Partners LLC, Kurobe leverages a licensed product from a Japanese company to address this critical healthcare need. The company's core mission is to advance biopharmaceutical solutions for challenging infections, with a vision to improve patient outcomes through innovative therapies.

Notable figures affiliated with Kurobe include Barry Butler, who serves as President and CEO and was previously CEO of Sirion Holdings Inc. Point Guard Partners, established by former executives of Sirion Holdings, supports Kurobe's initiatives. Key achievements include the successful licensing and development of their MRSA treatment product. Kurobe's impact lies in its targeted approach to combating antibiotic-resistant infections, addressing a significant gap in ophthalmic care.

Kurobe Pharmaceuticals - Similar Companies

Kurve Therapeutics logo

Kurve Therapeutics

kurvetx.com

MBC Pharma logo

MBC Pharma

mbcpharma.com

Corbus Pharmaceuticals Holdings logo

Corbus Pharmaceuticals Holdings

corbuspharma.com

pH Pharma logo

pH Pharma

ph-pharma.com

Alkeus Pharmaceuticals logo

Alkeus Pharmaceuticals

alkeus.com

Tarsus Pharmaceuticals logo

Tarsus Pharmaceuticals

tarsusrx.com

EyePoint logo

EyePoint

Ocuphire Pharma logo

Ocuphire Pharma

ocuphire.com

Surface Pharmaceuticals logo

Surface Pharmaceuticals

surfacepharma.com

OcuCure Therapeutics logo

OcuCure Therapeutics

Zocere logo

Zocere

zocere.com

Kinnear Pharmaceuticals logo

Kinnear Pharmaceuticals

kinnearpharma.com

Microbion logo

Microbion

microbioncorp.com

Veloce BioPharma logo

Veloce BioPharma

Zurex Pharma logo

Zurex Pharma

zurexpharma.com

Kurobe Pharmaceuticals - Quick Facts

Who are Kurobe Pharmaceuticals' competitors?

Companies similar to Kurobe Pharmaceuticals include Kurve Therapeutics, MBC Pharma, Corbus Pharmaceuticals Holdings and pH Pharma.

When was Kurobe Pharmaceuticals founded?

Kurobe Pharmaceuticals was founded in 2012.

Where is Kurobe Pharmaceuticals' headquarters located?

Kurobe Pharmaceuticals' headquarters is located in Tampa, FL, US.

When was Kurobe Pharmaceuticals' last funding round?

Kurobe Pharmaceuticals' most recent funding round was for $5M (USD) in June 2013.

How much has Kurobe Pharmaceuticals raised to-date?

As of Jun 4, 2013, Kurobe Pharmaceuticals has raised a total of $5M (USD).

How many employees does Kurobe Pharmaceuticals have?

Kurobe Pharmaceuticals has 5 employees as of Feb 5, 2024.

Kurobe Pharmaceuticals - Classification

Ownership
  • Private Equity
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 13 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research